ACE and congestive heart failure: All CHF patients enrolled in this project were NYHA class III, in most cases of ischemic etiology, were on stable individually adjusted medical therapy regimes, including angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists (100%), diuretics (100%), beta-blockers (100%).